Article feature image

Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q2 2021 Results – Earnings Call Transcript

Stock Analysis

Intellia Therapeutics, Inc. (NTLA) Q2 2021 Earnings Conference Call August 5, 2021 8:00 AM ET
Company Participants
Ian Karp – Senior Vice President of Investor Relations & Corporate Communications
John Leonard – Chief Executive Officer
David Lebwohl – Chief…

Click here to view the original article.

Tags:
,
Facebook Google+ Twitter Pinterest

Related Posts